The good opening du Wall Street, especially as regards the Nasdaq, seems to have renewed confidence that European markets were breathing this morning. In Paris the Cac 40 marks an increase of 2.21% at 3357 points, Frankfurt’s DAX 30 also positive with the Frankfurt +1.07%, while in London the FTSE 100 gaining 0.42%.
Posts Tagged ‘market’
Wall Street renewed confidence of European stock exchanges
March 15th, 2010New European markets anchored in the red
March 14th, 2010The negative closing scored last night by heavy Nasdaq technology stocks this morning on the old continent. To pay the bill are the new markets that sail firmly in negative territory. In Paris Nouveau Marché marks a decline of 0.95% to 638 points and in Frankfurt Nemax 50 loses 1, 79% to 526 points.
Related posts
Biosearch valued 21.09 euros per share from Versicor
March 14th, 2010The operation Versicor Biosearch configures itself as an acquisition of the first against the second, which will be acquired through a capital increase from 260.7 million dollars spent. Subsequently the two companies are merging and the new entity, provisionally called Versicor, will be owned 55% by the shareholders Americans and the rest from the Italians. Due diligence has enhanced Biosearch $ 21.43, equivalent to 21.09 euros in the session taken as reference. Italian company’s shareholders will get 1.77 shares Versicor each action Biosearch. The transaction, approved by their board, must pass the scrutiny of the meetings, which should conclude the work in the first quarter of 2003. The new company will benefit from dual listing, and the Nasdaq is the New Market, but the non-authorization of the Italian price is a condition precedent to the transaction, as well as the withdrawal of a shareholder of Biosearch. The new Board Board of Directors will be chaired by James H. Cavanaugh, one of the four members of the Board of Directors of Versicor that, along with four members of the Board of Directors of Biosearch, will form the board of the new società.George F. Horner III, current CEO of Versicor, will maintain the same position while Claudio Quarta, to present Biosearch of Italy, will become general manager of the new company. Francesco Parenti is Chief Scientific Officer, with overall responsibility for the discovery and preclinical development. Richard White, currently Chief Scientific Officer of Versicor, will continue as Chief Scientific Officer for North America. “Versicor shall cooperate with the Biosearch 1998 and after four years of collaboration we are confident that our two corporate cultures can marry perfectly and that combining the companies can more effectively achieve our common goal of launching new antibacterial and antifungal agents on the market” have indicated American society.
Related posts
The new European markets more resistant in the sign ‘
March 13th, 2010The new markets in the continent resist plus despite signs that come from the uncertain future on the Nasdaq. In Paris Nouveau Marché marks an increase of 1, 08% to 641 points. Even Frankfurt Nemax 5 resists in positive ground, although with a limited upside, and earn 0.14% to 551 points.
Related posts
European petroleum banner sales
March 13th, 2010The sales that dominate the European financial markets did not neglect to also affect the oil sector, which despite the dollar is back above parity with the euro surf the negative terrain. In Paris, Total Fina Elf marks a decrease of 2.6% to 123.7 euros, Royal Dutch leaves at ground level from 3.37% and Spain’s Repsol marks -4.72% to 40.68 euros.
Related posts
Morgan Stanley raises the feedback for Linde
March 12th, 2010Analysts at Morgan Stanley have revised upward their opinion on the title Linde German chemist, leading to overweight. Tsato price target is set at 63 euros. According to analysts, the title retains a good margin of appreciation, thanks to a good market positioning and breathing the air of renewal nela company pending the arrival of new CEO. But is all the chemical sector to be attractive according to reports from Morgan Stanley, which assesses a 20% growth potential. This morning the title Linde marks an increase of 2.8% to 47.8 euros.
Related posts
Futures, the market from ‘the go
March 12th, 2010Piazza Affari stores the day of onset of future actions with a higher than expected. The contracts total equity on the five affected were 1671 with a peak of operations in future Unicredit (1,082 contracts), followed by Telecom (313), Tim (252), Eni (20) and Enel (4).
Related posts
NM on, good BB Biotech and Acotel
March 12th, 2010The New Market (+2.2% on Numtel) is in positive terrain after a half hour of trading, mirroring a list in which the vast majority of titles by browsing the positive terrain. Well Tiscali (+2.2% to 5.33 euros), but mostly on watching e.Biscom (+3.4% at 25.33 euros) and BB Biotech (+4.2% to 44.8 million) . Among the titles still less well Acotel, which does not stop the race despite the title has almost doubled in price last month. Well also Novuspharma, an increase of 5.4% to 21.19 euros. In the title in question had gone down a lot in the last period, arriving at a market capitalization that took into account even now the value of the box.
Related posts
Continental pro-forma loss lower estimates
March 11th, 2010Continental Airlines reported a loss in the second quarter below analysts’ expectations. The result was negative for about 35 million dollars, equivalent to 55 cents per share, compared with 76 cents loss estimated by the market. Including unusual items, the company closed the quarter with a loss of $ 139 million, or $ 2.18 per share, compared with a profit of $ 42 million (74 cents per share) during the same period in 2001. Revenues from passengers dropped by 15% to $ 2.1 billion in the quarter.
Related posts
Autogrill ready to challenge the big business
March 11th, 2010The group Autogrill sharpen their weapons and prepares for the arrival on the Italian market of major rivals such as the Compass English and French Elior. Autogrill while celebrating its twenty-fifth birthday are in fact the expiring contracts of less than 43 licenses and is likely that foreign giants decide to bet on our market.